[Edaily Starin YUN GI BACK Reporter] NCT’s WISH is accelerating its push into the Japanese market as it kicks off promotions for its new single there. From showcases to TV appearances and large-scale promotional events, the group is continuing its upward momentum in Japan. NCT WISH (Photo: SM Entertainment) According to their agency, SM Entertainment, NCT WISH held a showcase on the 16th at the DiverCity Tokyo Plaza Festival Plaza in Tokyo to celebrate the release of their Japanese single “YO-I-DON! / BOY MEETS GIRL.” The venue was packed with fans who had gathered to see the members, and the event concluded amid enthusiastic cheers. On this day, the members performed the double title tracks “YO-I-DON!” and “BOY MEETS GIRL” for the first time, heating up the atmosphere with their signature refreshing energy and dynamic performances. They also took time to interact closely with fans through various events, including quizzes and talk segments related to the new songs. The showcase gained added significance as DJ KOO of the Japanese group TRF—who released the original version of “Boy Meets Girl”—served as the host. After watching the remake performance, reinterpreted in NCT WISH’s unique style, he delivered a message of support, further heating up the atmosphere on site. Their activities in Japan will continue. NCT WISH will run large-scale outdoor advertisements in the Shibuya area through the 28th, followed by appearances on major broadcasts such as TV Tokyo’s “Chocho Ultrasound” and NHK’s music program “Venue 101 EXTRA” to meet with Japanese fans. Member Riku is also set to take the stage for a special collaboration on TBS’s “Music Day 2026,” further expanding his presence.
A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
(Graphic: Generative AI)
During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…